Portective Action of Angiotensin Converting Enzyme Inhibitors on Cardiac Hypertrophy in the Aortic-Banded Rat.
Authors:
- 1 January 1999
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in Japanese Heart Journal
- Vol. 40 (5) , 645-654
Abstract
Imidapril, enalapril and quinapril were subcutaneously administered to aortic-banded rats by osmotic minipumps to compare the suppressive actions of these angiotensin converting enzyme (ACE) inhibitors on pressure-induced cardiac hypertrophy. Among the three drugs tested, imidapril was most potent for the prevention of cardiac hypertrophy, although equipotent hypotensive doses were used. Imidapril reduced both serum and cardiac ACE activities, while enalapril reduced only the former. Quinapril also reduced both, however, it was less potent at reducing the former compared to imidapril. Moreover, only imidapril significantly decreased left ventricular end diastolic pressure, which tended to be increased by aortic-banding. The lipophilicity of ACE inhibitors could not explain the more potent suppressive action of imidapril on cardiac hypertrophy because the lipophilicity of imidaprilat, an active metabolite of imidapril, was as low as an active metabolite of enalapril; i.e., much lower than an active metabolite of quinapril. The efficacy of ACE inhibitors on pressure-induced cardiac hypertrophy depends not only on an inhibitory effect on cardiac ACE activity, but also on other actions such as their effect on left ventricular end diastolic pressure.Keywords
This publication has 20 references indexed in Scilit:
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of internal medicine (1960), 1997
- Incidence of cough induced by imidapril in patients with hypertension with enalapril-associated coughCurrent Therapeutic Research, 1997
- Studies on the Magnitude and the Mechanism of Cough Potentiation by Angiotensin-Converting Enzyme Inhibitors in Guinea-pigs: Involvement of Bradykinin in the PotentiationJournal of Pharmacy and Pharmacology, 1996
- Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissueBiochemical Pharmacology, 1995
- Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a controlJournal Of Hypertension, 1995
- Role of bradykinin in the antihypertensive and cardioprotective actions of converting enzyme inhibitorsCanadian Journal of Physiology and Pharmacology, 1995
- Studies on angiotensin I converting enzyme (ACE) inhibitory effect of imidapril. (I). Inhibition of various tissue ACEs in vitro.Folia Pharmacologica Japonica, 1992
- Regression of Left Ventricular Hypertrophy - A Meta-AnalysisClinical and Experimental Hypertension. Part A: Theory and Practice, 1992
- Mechanisms of cardiovascular drugs as antioxidantsJournal of Molecular and Cellular Cardiology, 1990
- Left Ventricular Hypertrophy and Risk of Cardiac FailureJournal of Cardiovascular Pharmacology, 1987